AUA 2018: Photocure to Present New Data on Cysview® at the 2018 American Urological Association Annual Meeting

Truckee, CA ( -- Photocure ASA announced that Photocure will be exhibiting Blue Light Cystoscopy (BLC™) with Cysview in Booth 1825, during the American Urological Association Meeting (AUA 2018) in San Francisco, CA.

New data on Cysview will be presented in at least three posters, of which two are on registry studies using real-world longitudinal data, a plenary session on Patient Reported Outcomes and during the Bladder Cancer Surgical Technique session. Dr. James McKiernan will present on "Enhanced Cystoscopy: BLC – TURBT + Surveillance Video". Earlier this year BLC with Cysview was approved by the FDA for use in surveillance cystoscopy (in addition to the already existing approval for TURBT's (Trans Urethral Resection of the Bladder)).

"I have been using BLC with Cysview for both TURBT's and surveillance. I am looking forward to sharing my experience. Using these new techniques more broadly should result in improved patient outcomes," said Dr. James McKiernan, John K Lattimer Professor and Chairman of Urology at Columbia University and Urologist-in-Chief New York Presbyterian Hospital New York.
Photocure is also unveiling the company's strategic focus, exhibiting as The Bladder Cancer Company. "In this, the Bladder Cancer Awareness month, we are excited to announce our continued focus on bladder cancer and look forward to working with the bladder cancer community to increase awareness of Bladder Cancer and our breakthrough technology, BLC with Cysview," says Kjetil Hestdal, MD, PhD, President and CEO, Photocure ASA.

Key Activities featuring Cysview during the meeting include:

May 18, 2018 (Friday) 9:30 AM to 11:30AM – Location: MCC WEST, 3006
  • Blue Light Cystoscopy Improves Detection Rates: Updated Results From A Prospective Multicenter RegistryHow is outpatient blue light cystoscopy used in clinical routine? First results from the Nordic registryThe impact of Blue Light Cystoscopy on the response of induction BCG in patients with high-grade non-muscle invasive bladder cancer
May 19, 2018 (Saturday) – 4:33 PM to 4:42 PM – Location: MCC South, 208
  • Assessment of Blue Light Flexible Cystoscopy with Cysview on Patient Reported Outcomes– by Dr. Angela Smith, University of North Carolina
May 20, 2018 (Sunday) 7:00 AM to 9:00AM – Location: MCC WEST, 2005
  • Blue light in combination with Cysview Leads to Bladder Cancer Cell Death in an in vitro Mode
2:00 PM to 2:45 PM - MCC SOUTH, Esplanade (Plenary Session)
  • Surgical Techniques: Tips & Tricks: Bladder Cancer: Moderator: Dr. Kristen Scarpato – Vanderbilt University with other Panel Members: Dr. Joe Liao – VA Palo Alto and Dr. Bernie Bochner including: Dr. James McKiernan, New York Presbyterian, Columbia University, who will present on Enhanced Cystoscopy – BLC – TURBT + Surveillance Video plus moderated presentation
May 17 and 18 (Thursday and Friday), Photocure will be exhibiting at the AUA Office Practice Management Conference – Location: MCC North, 22

Read More:
Complete AUA 2018 Coverage
FDA Approval of New Indications for Blue Light Cystoscopy with Cysview®
TURBT More Important Than Ever